Signet healthcare partners, athyrium capital management, hildred capital and pharmascience inc. announce exit from pharmaceutics international, inc.

New york--(business wire)--a consortium of investors led by signet healthcare partners, athyrium capital management, hildred capital and pharmascience inc. today announced they have exited their equity stake in pharmaceutics international, inc. (“pii”), a contract development and manufacturing organization, and have closed on an undisclosed all-cash transaction to sell the company to jabil inc. (nyse: jbl), a global leader in engineering, manufacturing, and supply chain solutions. pii is a cont.
JBL Ratings Summary
JBL Quant Ranking